The whole‐cell cancer vaccines (WCCVs) with WCCV‐in‐shell structure with enhanced immunogenicity ascribing from the surface‐exposed calreticulin to promote dendritic cell recruitment, antigen presentation, and T‐cell activation. The gene discussed is CALR; the disease is cancer.